These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Is a control group necessary?]. Bonfill X; Porta Serra M Med Clin (Barc); 1987 Oct; 89(10):429-35. PubMed ID: 3316864 [No Abstract] [Full Text] [Related]
6. [Randomization and comparison of final quality in clinical studies]. Altman DG; Doré CJ Z Arztl Fortbild Qualitatssich; 2005; 99(10):629-34. PubMed ID: 16433266 [No Abstract] [Full Text] [Related]
7. [How to improve the quality of clinical trials]. Galende I; Sacristán JA; Soto J Med Clin (Barc); 1994 Apr; 102(12):465-70. PubMed ID: 8207997 [No Abstract] [Full Text] [Related]
8. [Quality of clinical information (II): Statistical significance]. Plasencia A; Porta Serra M Med Clin (Barc); 1988 Jan; 90(3):122-6. PubMed ID: 3280891 [No Abstract] [Full Text] [Related]
9. [Ethics of randomization]. Arpaillange P; Dion S Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599 [No Abstract] [Full Text] [Related]
10. [Breast cancer. Methods in intensely criticized research project]. Vesterdal A Sygeplejersken; 1988 Sep; 88(38):9. PubMed ID: 3217862 [No Abstract] [Full Text] [Related]
11. An efficient design for phase III studies of combination chemotherapies. Ellenberg SS; Eisenberger MA Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093 [No Abstract] [Full Text] [Related]
13. Proceedings of 'Methodologic issues in overviews of randomized clinical trials'. The National Heart, Lung and Blood Institute and The National Cancer Institute, Bethesda, Maryland, 15-16 May, 1986. Stat Med; 1987; 6(3):217-409. PubMed ID: 3616280 [No Abstract] [Full Text] [Related]
18. International differences in cardiovascular clinical trials. O'Shea JC; Califf RM Am Heart J; 2001 May; 141(5):866-74. PubMed ID: 11320381 [No Abstract] [Full Text] [Related]
19. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F; Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052 [No Abstract] [Full Text] [Related]
20. Advantages and drawbacks of the Zelen design for randomized clinical trials. Horwitz RI; Feinstein AR J Clin Pharmacol; 1980 Jul; 20(7):425-7. PubMed ID: 7430410 [No Abstract] [Full Text] [Related] [Next] [New Search]